Neurodegenerative Disease Clinical Trials

Preparing for Growth in Neurodegenerative Treatment Opportunities: How Clinical Teams can Best Position Study Design and Strategy to Reach Study Participants

John Hamlet; Christine Martino, MPM; Sabine Krofczik-Wilhelm, Ph.D.; Alberto Lledó, M.D., Ph.D.

PPD, part of Thermo Fisher Scientific

ALS

Applying Nanocatalysis to the Fight Against ALS

Rob Etherington

Neurodegenerative Diseases

Pioneering Nanocatalysis to Revolutionize Treatments for Neurodegenerative Diseases

Rob Etherington

Neurodegenerative Diseases

Uncovering New Drug Targets for Neurological Diseases

Brad Margus

Cerevance

Brain Organoids

Leveraging Organoids to Address Neurodegenerative Diseases

OrganoTherapeutics

Stem Cells

Changing the Paradigm of Stem Cell Technology

Sandy Solmon

Celavie Biosciences

Chronokines

Solving Unmet Clinical Needs by Harnessing the Science of Aging

Emilie Branch; Elizabeth Jeffords

Pharma's Almanac

Drug Repositioning

A Therapeutic Strategy for Neurological Disorders

Franck Mouthon; Mathieu Charvériat, Ph.D.

Theranexus

Cancer and Neurodegenerative Diseases

Leveraging the Cell Cytoskeleton for the Treatment of Cancer and Neurodegenerative Diseases

Maurice Zauderer, Ph.D.

Vaccinex, Inc.

Dementia

Single Gene Identified as Culprit in Early-Onset Dementia

Pharma's Almanac